arrow
Back
A

Antonio C. Wolff

johns hopkins sidney kimmel comprehensive cancer center

99H-index
903Paper Count
5.9WCitation Count
Published Papers 242
Publication Date
Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer
err2026-08-13
err0
PREAI
errPaul Cottu; Tomas Pascual; Jerôme Lemonnier; Huilin Hu; Estelle Roux; Roisin M. Connolly; Cynthia X. Ma; Antonio C. Wolff; Thayane Crestani; Pablo Tolosa; Juan M. Ferrero-Cafiero; Antonio Mulero-Sánchez; Fernando Salvador; Guillermo Villacampa; Joaquín Gavilá; Thibault de La Motte Rouge; Aleix Prat
errShare
errSave
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171
errCancer
IF5.1
err2026-05-29
err0
errOAAI
errTarah J. Ballinger MD; Fengmin Zhao PhD; Guanglong Jiang PhD; Fei Shen MD; David Cella PhD; John D. Peipert PhD; Kathy D. Miller MD; Antonio C. Wolff MD; Angela M. DeMichele MD; Bryan P. Schneider MD; Lynne I. Wagner PhD
errShare
errSave
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
err2026-05-01
err0
PREAI
errAbdou, Yara; Rozenblit, Mariya; Trapani, Dario; Zerdes, Ioannis; Boudreau, Erin; Zhou, Yang; Adam, Virginie; Barrios, Carlos; Bousrih, Chayma; Branch, Vernal; Carey, Lisa A.; Cameron, David; Chen, Samantha; Chua, Boon H.; Davidson, Nancy E.; Domchek, Susan M.; El-Abed, Sarra; El-Ashry, Dorraya; Flowers, Margaret; Foldi, Julia; Garber, Judy; Goulioti, Theodora; Hodgdon, Christine; Hung, Jessica L. C.; Klar, Natalie; Norton, Larry; Parajuli, Ritesh; Piccart, Martine; Pollastro, Teri; Santa-Maria, Cesar A.; Schumacher-Wulf, Eva; Stecklein, Shane R.; Thulin, Anna; Tovey, Holly; Winer, Eric; Wolff, Antonio C.; Lin, Nancy U.; O'Reilly, Seamus
errShare
errSave
Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results
err2026-03-18
err0
errOAAI
errRashmi K. Murthy; Barbara J. O’Brien; Donald A. Berry; Akshara Singareeka-Raghavendra; Maria Gule Monroe; Jason Johnson; Jason White; Jill Schwartz-Gomez; Ariel Topletz-Erickson; Mina Lobbous; Kristen Riley; Michelle Melisko; Aki Morikawa; Sherise D. Ferguson; John F. de Groot; Ian E. Krop; Vicente Valero; Mothaffar F. Rimawi; Antonio C. Wolff; Debu Tripathy; Nancy U. Lin; Erica M. Stringer-Reasor
errShare
errSave
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
err2025-11-17
err0
errOAAI
errS.A. Hurvitz; S. Loi; J. O’Shaughnessy; A.F.C. Okines; S.M. Tolaney; J. Sohn; C. Saura; X. Zhu; D. Cameron; T. Bachelot; E. Hamilton; G. Curigliano; A.C. Wolff; N. Harbeck; N. Masuda; L. Vahdat; K. Zaman; F. Valdes-Albini; M. Block; T. Pluard
errShare
errSave
Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD
err2025-11-01
err0
errOAAI
errSadigh, Gelareh; Duan, Fenghai; Gareen, Ilana F.; Hancock, Judy; Sicks, Jorean D.; Thangarajah, Maryanne; Meisel, Jane L.; Torres, Mylin A.; Ramsey, Scott D.; Wolff, Antonio C.; Wagner, Lynne I.; Carlos, Ruth C.; Graetz, Ilana
errShare
errSave
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
err2025-10-17
err0
errOAAI
errE.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
errShare
errSave
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)
err2025-10-05
err0
PREAI
errMaeve A. Hennessy; Constantine Gatsonis; Heather Jacene; Roisin M. Connolly; Brian L. Burnette; Erica M. Stringer-Reasor; Justin Romanoff; Alexander Taurone; Ciara C. O’Sullivan; Huong T. Le-Petross; Vered Stearns; Amy M. Fowler; Shou-Ching Tang; Karla A. Sepulveda; Angela M. DeMichele; David A. Mankoff; Antonio C. Wolff
errShare
errSave
Understanding Associations Between Patient-Level Factors and Participation in a Breast Cancer Clinical Trial
err2025-08-20
err0
errOAAI
errNicole E. Caston; Luqin Deng; Courtney P. Williams; Emily B. Levitan; Andres Azuero; Russell Griffin; Karen L. Smith; Antonio C. Wolff; Michelle E. Melisko; Eileen H. Shinn; Kathleen Gallagher; Rebekah Angove; Stephanie B. Wheeler; Gabrielle B. Rocque
errShare
errSave
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
err2025-07-14
err0
PREAI
errGuillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
errShare
errSave
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errHennessy, Maeve A.; Cimino-Mathews, Ashley; Carter, Jodi M.; Kachergus, Jennifer M.; Ma, Yaohua; Leal, Jeffrey P.; Solnes, Lilja B.; Abramson, Vandana G.; Carey, Lisa A.; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C.; Wahl, Richard L.; Huang, Chiung-Yu; Stearns, Vered; Thompson, E. Aubrey; Connolly, Roisin M.
errShare
errSave
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
errRADIOLOGY
IF15.2
err2025-04-01
err0
PREAI
errSlavkova, Kalina P.; Kang, Ruya; Kazerouni, Anum S.; Biswas, Debosmita; Belenky, Vivian; Chitalia, Rhea; Horng, Hannah; Hirano, Michael; Xiao, Jennifer; Corsetti, Ralph L.; Javid, Sara H.; Spell, Derrick W.; Wolff, Antonio C.; Sparano, Joseph A.; Khan, Seema A.; Comstock, Christopher E.; Romanoff, Justin; Gatsonis, Constantine; Lehman, Constance D.; Partridge, Savannah C.; Steingrimsson, Jon; Kontos, Despina; Rahbar, Habib
errShare
errSave
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial) (vol 315, e241628, 2025)
errRADIOLOGY
IF15.2
err2025-04-01
err0
PREAI
errSlavkova, Kalina P.; Kang, Ruya; Kazerouni, Anum S.; Biswas, Debosmita; Belenky, Vivian; Chitalia, Rhea; Horng, Hannah; Hirano, Michael; Xiao, Jennifer; Corsetti, Ralph L.; Javid, Sara H.; Spell, Derrick W.; Wolff, Antonio C.; Sparano, Joseph A.; Khan, Seema A.; Comstock, Christopher E.; Romanoff, Justin; Gatsonis, Constantine; Lehman, Constance D.; Partridge, Savannah C.; Steingrimsson, Jon; Kontos, Despina; Rahbar, Habib
errShare
errSave
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
err2025-03-01
err0
PREAI
errShinn, Eileen; Zahrieh, David; Demichele, Angela; Zdenkowski, Nick; Lemieux, Julie; Mao, Jun; Bjelic-Radisic, Vesna; Naughton, Michelle J.; Pfeiler, Georg; Gelmon, Karen; Balko, Justin M.; Egle, Daniel; Zoppoli, Gabriele; Traina, Tiffany; Jimenez, Miguel Martin; Novoa, Silvia Antolin; Haddad, Tufia; Chan, Arlene; Ring, Alistair; Wolff, Antonio; Symmans, William Fraser; Ponce Lorenzo, Jose; Sabanathan, Dhanusha; Burstein, Hal J.; Nowecki, Zbigniew Ireneusz; Pristauz-Telsnigg, Gunda; Brufsky, Adam; Bellet-Ezquerra, Meritxell; Foukakis, Theodoros; Novik, Yelena; Rubovszky, Gabor; Singer, Christian F.; Muehlbacher, Karoline; Filho, Otto Metzger; Goulioti, Theodora; Law, Ernest; Partridge, Ann H.; Carey, Lisa A.; Zoroufy, Alex; Hlauschek, Dominik; Fesl, Christian; Mayer, Erica L.; Gnant, Michael
errShare
errSave
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
err2025-01-23
err0
errOAAI
errDemichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H.; Pfeiler, G.; Zdenkowski, N.; Wolff, A.; Bellet-Ezquerra, M.; Winer, E.; Balic, M.; Miller, K.; Colleoni, M.; Lake, D.; Rubovsky, G.; Cameron, D.; Balko, J.; Singer, C. F.; Nowecki, Z.; Iwata, H.; Wolmark, N.; Parraga, K. A.; Rugo, H.; Steger, G. G.; Traina, T.; Werutsky, G.; Czajkowska, D.; Metzger, O.; El-Abed, S.; Theall, K. P.; Lu, R. D.; O'Brien, P.; Fesl, C.; Mayer, E.; Gnant, M.
errShare
errSave
HER2DX genomic test in early-stage HER2-positive breast cancer
err2024-12-01
err0
PREAI
errTolaney, S. M.; Tung, N.; Wolff, A. C.; DeMichele, A.; Cejalvo, J. M.; Martinez-Saez, O.; Pascual, T.; Waks, A. G.; Martin, M.; Ciruelos, E.; Harbeck, N.; Carey, L. A.; Cortes, J.; Curigliano, G.; Prat, A.
errShare
errSave
CNS METASTATIC PATTERNS IN BREAST CANCER TREATED WITH CDK4/6 INHIBITORS: PRELIMINARY RESULTS OF A RETROSPECTIVE ANALYSIS
err2024-11-11
err0
PREAI
errBazer, Danielle A.; Reiss, Justus; Sherief, Mohamed; Zhou, Yuan; Martinez, Daniel Heinemann; Parampil, Amy; Torroella, Jordina Rincon; Wolff, Antonio C.; Couzi, Rima; Stearns, Vered; Wilkinson, Mary; Jelovac, Danijela; Tao, Jessica; Sheng, Jenni; Canzoniero, Jenna, V; Santa-Maria, Cesar; Kamson, David O.; Sahebjam, Solmaz
errShare
errSave
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
err2024-11-01
err1
errOAAI
errFreedman, R. A.; Heiling, H. M.; Li, T.; Trapani, D.; Tayob, N.; Smith, K. L.; Davis, R.; Pereslete, A. M.; Demeo, M. K.; Cotter, C.; Chen, W. Y.; Parsons, H. A.; Santa-Maria, C. A.; Van Poznak, C.; Moy, B.; Brufsky, A. M.; Melisko, M. E.; o'Sullivan, C. C.; Ashai, N.; Rauf, Y.; Nangia, J. R.; Burns, R. T.; Savoie, J.; Wolff, A. C.; Winer, E. P.; Rimawi, M. F.; Krop, I. E.; Lin, N. U.
errShare
errSave
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
err2024-07-05
err0
errOAAI
errMezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A.; Arteaga, Carlos L.; Yang, Ximing J.; Wagner, Lynne I.; Cella, David; Meropol, Neal J.; Alpaugh, R. Katherine; Saphner, Thomas J.; Swaney, Robert E.; Hoelzer, Karen L.; Gradishar, William J.; Abramson, Vandana G.; Sundaram, P. Kothai; Jilani, Shamim Z.; Perez, Edith A.; Lin, Nancy U.; Jahanzeb, Mohammad; Wolff, Antonio C.; Sledge, George W.; Reid, Sonya A.
errShare
errSave